NewKerala.com

Russian Scientists Boost Cancer Drug Potency with Novel Chemical Method

Scientists at Lobachevsky State University have developed a novel chemical method to significantly enhance the effectiveness of anti-cancer drugs. The technique works by incorporating multiple aminomethyl groups into a drug's active molecules, strengthening their interaction with cancer cells. A key advantage is its ability to potentially upgrade already-approved pharmaceuticals without creating entirely new compounds. The high-yield, high-purity synthesis process also shows strong promise for future pharmaceutical development and industrial production.

Key Points: Russian Scientists Develop Method to Boost Cancer Drug Effectiveness

  • Enhances drug potency
  • Adds pharmacophore groups
  • Upgrades approved drugs
  • High-yield, pure synthesis
2 min read

Russian scientists develop method to boost effectiveness of Anti-Cancer medicines

Russian researchers create a chemical technique to enhance anti-cancer drugs by reinforcing active ingredients, potentially upgrading existing treatments.

"The reinforcing chemical groups can be added directly to existing pharmaceutical substances - TV BRICS"

Moscow, January 15

Researchers in Russia have devised a novel chemical technique that could markedly enhance the potency of anti-cancer drugs by reinforcing their active ingredients, offering fresh momentum to oncology research, as reported by TV BRICS.

The development has been made by scientists at Lobachevsky State University of Nizhny Novgorod, who are working on methods to improve biologically active compounds known for inhibiting tumour cell growth.

According to the researchers, the newly developed approach allows for the incorporation of multiple aminomethyl groups into biologically active molecules. These groups function as pharmacophore elements, which play a critical role in determining how effectively a drug interacts with cancer cells. By strengthening these key fragments, the therapeutic impact of anti-tumour medicines can be significantly amplified.

According to TV BRICS, the research team highlighted that one of the most important features of the method is its versatility. The reinforcing chemical groups can be added directly to existing pharmaceutical substances, which means that well-known and already approved drugs could potentially be upgraded without the need to develop entirely new compounds from scratch. This opens up wide-ranging opportunities for improving established cancer treatments and accelerating innovation in drug design. The findings have been reported on the official website of Lobachevsky State University.

Efficiency is another major advantage of the technique. The synthesis process achieves a product yield of nearly 90 per cent, while the purity of the final compound exceeds 95 per cent. Such high performance indicators are considered highly favourable for further research, as well as for possible use in large-scale pharmaceutical development and industrial production.

Beyond enhancing known anti-cancer medicines, the method is also being applied to create entirely new biologically active substances. This includes the synthesis of complex nitrogen-containing heterocycles, compounds that are widely regarded as having strong therapeutic potential.

The researchers believe that the approach could contribute to the development of more effective and targeted anti-cancer treatments in the coming years.

- ANI

Share this article:

Reader Comments

A
Aditya G
Great to see international collaboration through BRICS paying off. The 90% yield and 95% purity are impressive numbers for scaling up. Hope Indian research institutes like IISC or TIFR can also collaborate on such projects.
R
Robert G
While the science sounds solid, the real test is clinical trials. Many promising lab results fail there. I appreciate the optimism, but let's temper expectations until we see human trial data. The article doesn't mention that phase.
S
Sneha F
My mother is undergoing chemotherapy. Reading this gives me hope. The idea of making current drugs more potent without starting from zero could be a game-changer. Wishing the scientists all the best. Jai Hind!
K
Karthik V
Interesting read. The focus on "nitrogen-containing heterocycles" is key – that's a hot area in medicinal chemistry. Hope our pharma companies in Hyderabad and Bengaluru are paying attention. This could streamline our generic drug production too.
M
Meera T
Good step forward, but we must ensure such advancements don't remain confined to expensive imported medicines. The government should have policies to license such tech for Indian manufacturers. Affordable healthcare is the need of the hour.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50